Cargando…

The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies

Immune checkpoint inhibitors (ICIs) have a modest clinical activity when administered as monotherapy against breast cancer (BC), the most common malignancy in women. Novel combinatorial strategies are currently being investigated to overcome resistance to ICIs and promote antitumor immune responses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melaiu, Ombretta, Vanni, Gianluca, Portarena, Ilaria, Pistolese, Chiara Adriana, Anemona, Lucia, Pomella, Silvia, Bei, Roberto, Buonomo, Oreste Claudio, Roselli, Mario, Mauriello, Alessandro, Barillari, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964596/ https://www.ncbi.nlm.nih.gov/pubmed/36834641 http://dx.doi.org/10.3390/ijms24043226

Ejemplares similares

The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview
por: Barillari, Giovanni, et al.
Publicado: (2022)

Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency
por: Vanni, Gianluca, et al.
Publicado: (2020)

MR imaging-guided vacuum assisted breast biopsy: Radiological-pathological correlation and underestimation rate in pre-surgical assessment
por: Meucci, Rosaria, et al.
Publicado: (2020)

New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes
por: Buonomo, Oreste Claudio, et al.
Publicado: (2017)

Ultrasound-Guided Laser Ablation After Excisional Vacuum-Assisted Breast Biopsy for Small Malignant Breast Lesions: Preliminary Results
por: Perretta, Tommaso, et al.
Publicado: (2021)

DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma
por: Pomella, Silvia, et al.
Publicado: (2023)

Breast Trauma and Triple-Negative Hemorrhagic Cystic Carcinoma: Management and Treatment
por: Cotesta, Maria, et al.
Publicado: (2020)

Dynomics: A Novel and Promising Approach for Improved Breast Cancer Prognosis Prediction
por: Inglese, Marianna, et al.
Publicado: (2023)

COVID-19 Unintended Effects on Breast Cancer in Italy After the Great Lockdown
por: Oldani, Chiara, et al.
Publicado: (2020)

DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy
por: Cifaldi, Loredana, et al.
Publicado: (2023)

Case Report: Early Breast Cancer Recurrence Mimicking BIA-ALCL in a Patient With Multiple Breast Procedures
por: Materazzo, Marco, et al.
Publicado: (2021)

A BRCA2 germline mutation and high expression of immune checkpoints in a TNBC patient
por: Han, Yuyi, et al.
Publicado: (2023)

Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy
por: D’Amico, Silvia, et al.
Publicado: (2022)

Immunogenic Chemotherapy Sensitizes Renal Cancer to Immune Checkpoint Blockade Therapy in Preclinical Models
por: Cui, Shujin
Publicado: (2017)

Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations
por: Principe, Nicola, et al.
Publicado: (2022)

Editorial: Cell network in antitumor immunity of pediatric and adult solid tumors
por: Pesce, Silvia, et al.
Publicado: (2023)

Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
por: Peranzoni, Elisa, et al.
Publicado: (2020)

Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress
por: Ferroni, Patrizia, et al.
Publicado: (2015)

Small vascular lesions of the breast diagnosed by magnetic resonance imaging‐guided vacuum assisted biopsy: Report of 2 cases
por: Perretta, Tommaso, et al.
Publicado: (2022)

Breast Cancer Diagnosis in Coronavirus-Era: Alert From Italy
por: Vanni, Gianluca, et al.
Publicado: (2020)

Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy?
por: Riondino, Silvia, et al.
Publicado: (2023)

Primary Extranodal Follicular T-Cell Lymphoma and Ductal Breast Carcinoma Diagnosed by a Magnetic Resonance Imaging-Guided Vacuum-Assisted Biopsy: A Case Report
por: Meucci, Rosaria, et al.
Publicado: (2021)

RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade
por: Ruzicka, Michael, et al.
Publicado: (2019)

Corticosteroids and immune checkpoint blockade
por: Min, Le, et al.
Publicado: (2015)

Immune checkpoint blockade in HIV
por: Gubser, Celine, et al.
Publicado: (2022)

VEGF blockade damages brain vessels
por: Bashyam, Hema
Publicado: (2008)

MCT4 blockade increases the efficacy of immune checkpoint blockade
por: Babl, Nathalie, et al.
Publicado: (2023)

Update on checkpoint blockade therapy for lymphoma
por: Kline, Justin, et al.
Publicado: (2015)

Immune checkpoint blockade in ovarian cancer
por: Weiss, Lukas, et al.
Publicado: (2016)

LIGHTing tumor up for checkpoint blockade
por: Liang, Yong, et al.
Publicado: (2016)

Hallmarks of response to immune checkpoint blockade
por: Cogdill, Alexandria P, et al.
Publicado: (2017)

Immune-Checkpoint Blockade Therapy in Lymphoma
por: Kuzume, Ayumi, et al.
Publicado: (2020)

Activation of phagocytosis by immune checkpoint blockade
por: Li, Chia-Wei, et al.
Publicado: (2018)

Neutrophils in the era of immune checkpoint blockade
por: Faget, Julien, et al.
Publicado: (2021)

Role of Breast-Conserving Surgery on the National Health System Economy From and to SARS-COVID-19 Era
por: Buonomo, Oreste Claudio, et al.
Publicado: (2022)

Nanomaterials-based precision sonodynamic therapy enhancing immune checkpoint blockade: A promising strategy targeting solid tumor
por: Dai, Xinlun, et al.
Publicado: (2023)

48218 Preclinical modeling of BRAF(V600E)/PTEN-/- melanoma leptomeningeal disease (LMD) to assess intrathecal checkpoint blockade
por: Guerrieri, Renato A., et al.
Publicado: (2021)

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
por: Melaiu, Ombretta, et al.
Publicado: (2020)

Anlotinib Induces a T Cell–Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma
por: Su, Yudong, et al.
Publicado: (2022)

Inhibiting the inhibitors: Checkpoints blockade in solid tumors
por: Mavilio, Domenico, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2ll7haquvflh4atsokj72rokd5